Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v30-FR Version v25-EN
Language French English
Date Updated 2023-10-03 2023-04-04
Drug Identification Number 02256096 02256096
Brand name MYLAN-MIRTAZAPINE MYLAN-MIRTAZAPINE
Common or Proper name MIRTAZAPINE MIRTAZAPINE
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients MIRTAZAPINE MIRTAZAPINE
Strength(s) 15MG 15MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 100BT 100BT
ATC code N06AX N06AX
ATC description ANTIDEPRESSANTS ANTIDEPRESSANTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2022-09-09 2022-09-09
Actual start date 2022-09-09 2022-09-09
Estimated end date 2023-05-09 2023-05-23
Actual end date 2023-07-04
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments